Patentability Strategy Governance

10 Mar 2026 --
0 Comments

📌 1. Overview of Patentability Strategy Governance

Patentability strategy governance is the structured approach companies use to identify, protect, and manage inventions that are capable of being patented. It aligns R&D, legal, and corporate strategy to maximize the value of intellectual property (IP).

Objectives include:

Ensuring inventions meet patentability criteria (novelty, non-obviousness, industrial applicability).
Prioritizing patents with commercial or strategic value.
Aligning patent filings with business and R&D objectives.
Reducing litigation risk by ensuring freedom-to-operate.
Integrating internal governance for approvals, audits, and compliance.

📌 2. Key Elements of Patentability Governance

A. Patentability Assessment

Novelty Check: Ensure invention is new compared to prior art.
Non-Obviousness: Must not be obvious to a person skilled in the field.
Industrial Applicability: Must be capable of practical use.

B. Strategic Alignment

Business Relevance: Focus on patents that support products or technology roadmap.
Portfolio Management: Decide which patents to pursue, maintain, or abandon.

C. Internal Governance Structure

Approval Committees: Typically involve R&D heads, legal counsel, and executives.
Documentation Standards: Record invention disclosures, prior art searches, and filing decisions.
Audit & Monitoring: Regular review of IP portfolio to assess value and enforceability.

D. Risk Management

Freedom-to-Operate Analysis: Ensure patents don’t infringe third-party IP.
Validity Review: Evaluate potential weaknesses to prevent invalidation.
Jurisdictional Considerations: Filing strategy may vary across countries.

E. Licensing and Monetization Integration

Ensure patents are suitable for licensing, cross-licensing, or enforcement strategies.

📌 3. Legal and Regulatory Considerations

Patent Statutes: Must comply with the jurisdiction’s patent law (e.g., India’s Patents Act, US Patent Act).
Prior Art Disclosure: Failure to disclose relevant prior art can invalidate patents.
Employee Invention Policies: Ownership and assignment agreements must be clear.
Corporate Compliance: Board approvals for significant IP filings or enforcement actions.
Ethics and Competition: Avoid monopolistic or anti-competitive patent practices.

🧑‍⚖️ 4. Notable Case Laws

Case 1 — Diamond v. Chakrabarty (USA, 1980)

Issue: Patentability of genetically modified microorganisms.
Holding: Living organisms created by humans can be patented.
Lesson: Expands scope of patentable subject matter; guides corporate innovation strategy.

Case 2 — Mayo Collaborative Services v. Prometheus Laboratories, Inc. (USA, 2012)

Issue: Patentability of medical diagnostic methods.
Holding: Natural laws or abstract ideas are not patentable; inventive application is required.
Lesson: Governance must ensure technical contribution beyond natural phenomena.

Case 3 — Alice Corp. v. CLS Bank International (USA, 2014)

Issue: Patentability of computer-implemented business methods.
Holding: Abstract ideas implemented on a computer are not patentable unless inventive.
Lesson: Corporate patent strategy must evaluate software and business method inventions carefully.

Case 4 — Novartis AG v. Union of India (India, 2013)

Issue: Patentability of incremental pharmaceutical inventions.
Holding: Incremental improvements must show significant efficacy to be patentable.
Lesson: Governance policies must assess inventive step and practical utility.

Case 5 — Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co. (USA, 2002–2007)

Issue: Doctrine of equivalents in patent infringement.
Holding: Patent scope may extend beyond literal claims under certain conditions.
Lesson: Strategy governance must craft precise claims to maximize enforceability.

Case 6 — KSR International Co. v. Teleflex Inc. (USA, 2007)

Issue: Obviousness standard for patent invalidity.
Holding: Obvious combinations of prior art may invalidate patents.
Lesson: Corporate strategy must conduct thorough prior art searches and inventive step analysis.

Case 7 — Association for Molecular Pathology v. Myriad Genetics, Inc. (USA, 2013)

Issue: Patentability of isolated human genes.
Holding: Naturally occurring DNA is not patentable; cDNA may be patentable.
Lesson: Governance must distinguish naturally occurring vs engineered inventions.

📌 5. Steps for Effective Patentability Governance

Invention Disclosure & Evaluation
- Employees submit inventions; legal and technical teams assess patentability.
Prior Art & Patentability Search
- Conduct worldwide search to evaluate novelty and inventive step.
Strategic Selection
- Prioritize patents with commercial value or strategic relevance.
Board/Committee Approval
- Formal approval of patent filings, especially high-value or high-risk inventions.
Documentation & Record-Keeping
- Maintain detailed invention disclosures, prior art analyses, and filing rationale.
Ongoing Review & Portfolio Management
- Periodically review patents for enforcement, licensing, or abandonment.

✅ 6. Key Takeaways

Patentability strategy governance aligns R&D, legal, and business objectives to maximize IP value.
Effective governance requires:
- Structured internal committees for approval and review.
- Robust prior art search and inventive step assessment.
- Clear documentation and compliance with patent statutes.
Case law demonstrates:
- Novel subject matter expands patent scope (Diamond v. Chakrabarty).
- Obviousness and abstract ideas can invalidate patents (KSR v. Teleflex, Alice).
- Incremental innovations require tangible efficacy (Novartis v. India).
Strong governance minimizes litigation risk and strengthens portfolio monetization.